quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:19:42·24d
ANALYSTRating
Opus Genetics Inc. logo

Cantor Fitzgerald initiated coverage on Opus Genetics with a new price target

IRD· Opus Genetics Inc.
Health Care
Original source

Companies

  • IRD
    Opus Genetics Inc.
    Health Care

Recent analyst ratings

  • Mar 30UpdateCantor Fitzgerald$15.00
  • Mar 16UpdateOppenheimer$10.00
  • Jan 20UpdateBTIG Research$7.00
  • Dec 10UpdateB. Riley Securities$9.00
  • Nov 25UpdatePiper Sandler$7.00
  • Oct 29UpdateWedbush$8.00

Related

  • SEC9h
    SEC Form 144 filed by Opus Genetics Inc.
  • SEC9h
    SEC Form 144 filed by Opus Genetics Inc.
  • SEC1d
    SEC Form EFFECT filed by Opus Genetics Inc.
  • INSIDER1d
    SEC Form 4 filed by Rodgers Richard J
  • INSIDER1d
    SEC Form 4 filed by Manuso James S J
  • INSIDER1d
    SEC Form 4 filed by Benton Susan
  • INSIDER1d
    SEC Form 4 filed by Gallagher Cam
  • INSIDER1d
    SEC Form 4 filed by Graves Adrienne L
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022